propantheline has been researched along with Symptom Cluster in 3 studies
Propantheline: A muscarinic antagonist used as an antispasmodic, in rhinitis, in urinary incontinence, and in the treatment of ulcers. At high doses it has nicotinic effects resulting in neuromuscular blocking.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Schott, GD | 1 |
| Loh, L | 1 |
| Burbige, EJ | 1 |
| Manning, RJ | 1 |
| Belber, JP | 1 |
| Cameron, JL | 1 |
| Gayler, BW | 1 |
| Hendrix, TR | 1 |
3 other studies available for propantheline and Symptom Cluster
| Article | Year |
|---|---|
Anticholinesterase drugs in the treatment of chronic pain.
Topics: Arm; Cholinesterase Inhibitors; Chronic Disease; Humans; Leg; Male; Middle Aged; Neostigmine; Pain; | 1984 |
Watery diarrhea syndrome with elevated levels of vasoactive intestinal polypeptide associated with pancreatitis and pancreatic pseudocyst.
Topics: Adult; Diarrhea; Gastrointestinal Hormones; Humans; Male; Pancreatic Cyst; Pancreatitis; Propantheli | 1978 |
The use of intramuscular propantheline in the short bowel syndrome.
Topics: Adult; Female; Humans; Intestinal Diseases; Intestines; Postoperative Complications; Propantheline; | 1976 |